Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added, and the government funding lapse notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:19:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center status with a link to opm.gov for updates, and updated the revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T23:04:58.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and footer metadata updates: added a 'Show glossary' label, corrected capitalization of 'Last Update Submitted that Met QC Criteria', and updated the footer to include 'No FEAR Act Data' and 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-27T22:34:31.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Software template revision updated from v3.3.3 to v3.3.4. No study content or user-facing layout changes are apparent.
    Difference
    0.1%
    Check dated 2026-01-14T00:31:00.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page adds a Revision: v3.3.3 label and removes the HHS Vulnerability Disclosure and Revision: v3.3.2 links from the footer. These are administrative site updates with no impact on study content or user interaction.
    Difference
    0.1%
    Check dated 2025-12-23T08:10:51.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.3.1 to v3.3.2 on the page footer, with no observed changes to study details, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:23:20.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.